AGENTS D'INVERSION DE LIAISON POUR ANTICORPS ANTIFACTEUR XI/XIA ET UTILISATIONS CORRESPONDANTES

• 收藏
• 分享

专利权人:

NOVARTIS AG

发明人:

EWERT, STEFAN,KOCH, ALEXANDER WOLFGANG

申请号：

CA3083210

公开号：

CA3083210A1

申请日:

2018.11.20

申请国别(地区):

CA

年份:

2018

代理人:

摘要：

The present disclosure relates to reversal agents, which specifically bind to anti-Factor XI and/or anti-Factor XIa antibodies, and reverse one or more anticoagulant effects of the anti- Factor XI and/or anti-Factor XIa antibodies, as well as to methods of use thereof, such as methods for reversing anticoagulant effects of such anti-Factor XI and/or anti-Factor XIa antibodies, and to related methods for managing bleeding or bleeding risks.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/